Laboratory Monitoring in Hyperparathyroidism
For primary hyperparathyroidism, monitor serum calcium every 3 months during the first year of medical management, then at least twice yearly thereafter, with annual comprehensive assessment including 25-OH vitamin D, creatinine with eGFR, and urinary calcium excretion. 1
Initial Diagnostic Workup
When hyperparathyroidism is suspected, the essential laboratory tests include:
- Serum calcium (preferably ionized or corrected total calcium)
- Intact parathyroid hormone (PTH)
- 25-hydroxyvitamin D - must be measured and deficiency corrected before interpreting PTH levels 2, 3
- Serum phosphate
- Creatinine with estimated glomerular filtration rate (eGFR)
- 24-hour urinary calcium excretion (or spot urine calcium-to-creatinine ratio) 3, 4
Additional baseline assessment should include bone mineral density by dual-energy x-ray absorptiometry (DEXA) and renal imaging to evaluate for complications 3, 4.
Monitoring Under Medical Management (Non-Surgical)
The 2025 French expert consensus provides the most specific monitoring schedule 1:
First Year
- Serum calcium every 3 months (Grade A+++)
- This frequent monitoring detects disease progression early
After First Year
- Serum calcium at least twice yearly (Grade A+++)
- Annual comprehensive panel including:
- Serum calcium
- 25-OH vitamin D
- Creatinine with eGFR
- Urinary calcium excretion (24-hour or spot) (Grade B+)
Reassessment of Complications
- Bone and kidney function reassessed at 1 year, then at least every 2 years (Grade B+) 1
- This includes repeat DEXA scanning and renal imaging if complications were present initially
Post-Surgical Monitoring
After parathyroidectomy, monitoring requirements differ substantially 1, 5:
Immediate Postoperative Period
- Serum calcium measured the day after surgery
- PTH at 24 hours post-surgery - values >10 pg/mL identify patients who will not develop permanent hypoparathyroidism (Grade A++) 1
- Weekly serum calcium monitoring for the first month (Grade B+)
- If severe hypocalcemia develops, also measure PTH, phosphate, magnesium, and urinary calcium to distinguish hypoparathyroidism from hungry bone syndrome (Grade B+) 1
One Year Post-Surgery
- Comprehensive assessment including:
- Serum calcium
- 25-OH vitamin D
- Creatinine with eGFR
- Urinary calcium excretion
- PTH should NOT be measured routinely at one year (Grade B+) 1
- Reassess bone and kidney complications if present preoperatively (Grade A++) 1
Important Caveats
Vitamin D status must be optimized (>30 ng/mL or 75 nmol/L) before interpreting PTH levels, as vitamin D deficiency can elevate PTH and confound the diagnosis 1, 3. This is a Grade A+++ recommendation.
PTH assay generation matters: Different PTH assays (second vs. third generation) measure PTH fragments differently, which can affect clinical decisions, particularly in chronic kidney disease-related secondary hyperparathyroidism 6. However, for classic primary hyperparathyroidism diagnosis, the assay type is less critical since the diagnosis relies on the pattern (elevated or inappropriately normal PTH with hypercalcemia) rather than absolute values.
Hungry bone syndrome presents with severe hypocalcemia but normal or elevated PTH, along with hypophosphatemia and hypomagnesemia - distinguishing it from hypoparathyroidism requires measuring these additional parameters 1, 5.
The monitoring frequency can be adjusted based on disease severity, but the minimum frequencies outlined above from the 2025 guidelines represent the current standard of care for preventing complications while avoiding excessive testing.